Sensorium Therapeutics – Modern Neuroscience Technology Meets Ethnobotanical History for the Development of Mental Health Therapeutics
Dick Simon is co-founder and CEO of Sensorium Therapeutics, a drug discovery platform translating insights from nature and modern neuroscience to develop novel mental health therapeutics. The search for natural compounds with medicinal value is an underexplored area in the advancement of clinical-grade medicines. Dick talks about Sensorium’s proprietary drug discovery platform, which has created better tools to address these unique technical challenges with machine learning and through a significant library of psychoactive plants to pinpoint realistic drug candidates targeting mental health.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Mental health. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Mental health and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Mental health?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Dick Simon is co-founder and CEO of Sensorium Therapeutics, a drug discovery platform translating insights from nature and modern neuroscience to develop novel mental health the…
- Key Point: The search for natural compounds with medicinal value is an underexplored area in the advancement of clinical-grade medicines.
- Key Point: Dick talks about Sensorium’s proprietary drug discovery platform, which has created better tools to address these unique technical challenges with machine learning and through a…
- Key Point: Dick is a serial entrepreneur and leader in advancing psychedelic-assisted therapies.
- Key Point: He is the Chairman of the Advisory Council of Center for the Neuroscience of Psychedelics at Massachusetts General Hospital, Co- Founder and Board Member of the Boston Psychedel…
Dick Simon, Co-Founder & CEO. Dick is a serial entrepreneur and leader in advancing psychedelic-assisted therapies. He is the Chairman of the Advisory Council of Center for the Neuroscience of Psychedelics at Massachusetts General Hospital, Co- Founder and Board Member of the Boston Psychedelic Research Group, and on the steering committee for the Psychedelic Science Funders Collaborative. Dick received his undergraduate degree from Cornell University and his MBA from Harvard Business School. After September 11, 2001, Dick co-founded and led the YPO Peace Action Network which leverages personal and business relationships, resources, and expertise for conflict resolution on local and global levels. Dick’s work has earned him YPO’s Global Humanitarian Award, Harvard Business School’s Making a Difference Award, inclusion in Real Leaders magazine’s “100 Visionary Leaders” and in the “100 Most Influential People in Psychedelics” list.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



